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The human apoptosis-inducing factor (hAIF) is a moonlight flavoprotein involved in mitochondrial respiratory complex assembly
and caspase-independent programmed cell death. These functions might bemodulated by its redox-linked structural transition that
enables hAIF to act as a NAD(H/+) redox sensor. Upon reduction with NADH, hAIF undergoes a conformational reorganization in
two specific insertions—the flexible regulatory C-loop and the 190-202 β-harpin—promoting protein dimerization and the
stabilization of a long-life charge transfer complex (CTC) that modulates its monomer-dimer equilibrium and its protein
interaction network in healthy mitochondria. In this regard, here, we investigated the precise function of the β-hairpin in the
AIF conformation landscape related to its redox mechanism, by analyzing the role played by W196, a key residue in the
interaction of this motif with the regulatory C-loop. Mutations at W196 decrease the compactness and stability of the oxidized
hAIF, indicating that the β-hairpin and C-loop coupling contribute to protein stability. Kinetic studies complemented with
computational simulations reveal that W196 and the β-hairpin conformation modulate the low efficiency of hAIF as NADH
oxidoreductase, contributing to configure its active site in a noncompetent geometry for hydride transfer and to stabilize the
CTC state by enhancing the affinity for NAD+. Finally, the β-hairpin motif contributes to define the conformation of AIF’s
interaction surfaces with its physiological partners. These findings improve our understanding on the molecular basis of hAIF’s
cellular activities, a crucial aspect for clarifying its associated pathological mechanisms and developing new molecular therapies.
1. Introduction
The human apoptosis-inducing factor (hAIF) was first
described as a mitochondrial-released flavoprotein mediating
caspase-independent programmed cell death [1]. Moreover,
this ubiquitously expressed protein across eukaryotes also
plays a vital role in cell development and survival [2]. These
survival functions rely on its FAD-dependent activities,
which contribute to maintain the stability of the mitochon-
drial electron transfer chain, supercomplex organization,
and transmembrane potential, as well as to control mito-
chondrial reactive oxygen species (ROS) [3]. In healthy mito-
chondria, the hAIF is processed and the hAIFΔ1-53 mature
protein anchors in the inner membrane (IM)—via its N-
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terminal segment, facing the intermembrane space (IMS)—
and folds in three domains (Figure 1(a)) [4–6]. Mammalian
AIFs have two specific insertions, a regulatory C-terminal
loop (aa 510-560 in hAIF) and a β-hairpin (aa 190-202 in
hAIF), which connect the NADH and FAD domains to the
C-terminal proapoptotic domain (Figure 1(a)).
hAIF conformation is dynamically influenced by coen-
zyme substrate binding and by the redox switch of its flavin
cofactor, facts believed to modulate its biomolecular interac-
tion network [7, 8]. In oxidized hAIF (hAIFox), the regulatory
C-loop is stabilized in the protein core by direct interaction
with the β-hairpin, particularly through stacking and H-
bonding interactions of W196 and R201 residues with its
517-524 and 529-533 short helixes. Binding of one NADH
molecule to AIF’s active site (NADHA) promotes FAD
reduction, as well as the stabilization of a long-lived
FADH-/NAD+ charge transfer complex (CTC). This CTC is
inefficient in electron transfer, but capable of inducing a
redox-linked protein conformational reorganization and its
subsequent dimerization. CTC formation displaces the β-
hairpin that triggers C-loop remodeling and its release to
the solvent. These conformational changes induce (i) the
allosteric formation of the second noncatalytic NADH bind-
ing site (NADHB), where stacking interactions with reor-
iented W196 and F582 side chains facilitate NADHB
accommodation and (ii) the dimerization of the protein
(Figures 1(c) and 1(e)). These facts led to postulate AIF as a
redox sensor of NAD(H/+) cellular levels [9–11]. W196 sub-
stitution by alanine disrupts the interaction between the β-
hairpin and the C-loop that unwinds the above mentioned
529-533 helix and releases the two specific AIF insertions to
the solvent, promoting a permissive mutant dimerization in
its oxidized state (W196A hAIFΔ1-101ox, herein W196Aox)
(Figures 1(a) and 1(d)) [11]. However, W196Aox maintains
an active-site architecture similar to that of WT hAIFox for
residues involved in NADHA binding with the only excep-
tions of E453 and H454 (Figure 1(b)). The β-hairpin release
in W196Aox also induces the displacement of the central β-
strand and the reorientation of E453 and H454 side chains
(Figure S1D-E). Thus, H454 disrupts its interaction with
S480, producing as a consequence the displacement of the
H478 side chain—sited in the loop connecting the central
β-strand and the His-rich helix—towards the C-loop,
contributing to its release, and the exposition of the
hydrophobic border at the dimerization interfaces in the
W196Aox structure. Such last conformational changes are
similar to those reported for the WT CTC structure
(Figure S1E-F).
In healthy cells, hAIF is essential for mitochondrial bio-
energetics, being its physical and functional interaction with
human CHCHD4 (coiled-coil-helix-coiled-coil-helix
domain containing 4) key in the assembly and/or stabiliza-
tion of multisubunit respiratory transport chain complexes
and supercomplexes [12–15]. In IMS, CHCHD4 controls
the import and oxidative folding of a set of assembly factors
and protein subunits of respiratory complexes, while hAIF
would regulate CHCHD4 expression as well as its import
and proper IMS localization. Consequently, downregulation
or depletion of hAIF gives rise to major dysfunctions in oxi-
dative phosphorylation (OXPHOS), secondary to the defi-
ciency of CHCHD4, causing severe neurodegenerative
illnesses [12, 14, 16, 17]. The hAIF conformation—modulated
by its redox NADH-dependent monomer-dimer equilibriu-
m—is suggested to be critical for this interaction [7, 13, 18].
Upon lethal cellular stress, hAIF acts as a mediator of
necrotic poly(ADP-ribose) polymerase- (PARP-) 1-
dependent cell death (parthanatos) by its further processing
into the soluble proapoptotic form (hAIFΔ1-101) and its
release into the cytosol. The regulatory mechanism by which
AIF is released is unknown, but could be somehow modu-
lated by its structural reorganization due to depletion of
coenzyme levels during PARP-1 hyperactivation [19]. Once
in the cytosol, its interaction with some endonucleases, as
cyclophilin A (CypA), favors nuclear cotranslocation of the
AIF:CypA complex [20, 21]. In this subcellular compart-
ment, the association of this binary complex to the histone
H2AX leads to the assembly of the AIF-mediated DNA deg-
radation complex (“degradosome,” AIF:CypA:H2AX:DNA),
which provokes chromatin condensation and DNA fragmen-
tation [21, 22].
Despite the emerging picture of the physiological func-
tions of AIF being modulated by its conformational and
redox states, we are only starting to depict the implications
of the molecular mechanism regulating its activities. Thus,
the molecular basis for the mechanism by which AIF regu-
lates and pivots the redox-dependent interaction with
CHCHD4, as well as those for the action of the degradosome
complex as a death effector remain unknown. Nonetheless,
we can envisage that AIF ability to stabilize both stable
CTC and dimers—upon interaction with the coenzyme
followed by FAD reduction—is surely a key feature to switch
among its in vivo roles. In this context, the structural changes
induced by CTC formation in native protein, but also shared
by W196Aox, suggest that W196 and/or the β-hairpin might
be relevant for AIF cellular activities. Such hypothesis is fur-
ther supported by the β-hairpin contributing to binding of
the allosteric NADHB, as well as by the fact that pathogenic
mutations coursing with severe processes of neurodegenera-
tion and early death have been reported at both the NADHB
binding site and the β-hairpin itself.
In the present study, we particularly investigate the con-
tribution of the β-hairpin to the regulation of hAIF structural
stability, coenzyme binding, reductase activity, CTC stability,
and interaction with its physiological partners, by generating
W196A, W196L, and W196Y site-directed mutants (which
progressively reduce aromatic and stacking interactions).
Our results indicate that the W196 side chain is not only
key to establish the β-hairpin and C-loop organization in
the oxidized state, but also to regulate the stability and con-
formational landscape of the protein. Both facts seem to be
relevant to determine AIF efficiency as a cellular redox sen-
sor, as well as to the establishment of specific binary interac-
tions with different partners.
2. Materials and Methods
2.1. Expression and Production of Proteins. The cDNA
sequences encoding for W196Y, W196L, and W196A
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hAIFΔ1-101 variants (UniProtKB O95831) were obtained by
site-directed mutagenesis from Mutagenex® and then sub-
cloned into the pET28a expression vector with a cleavable
N-terminal His6-tag similar to that reported for the WT pro-
tein [10]. The cDNAs encoding for human CypA (Uni-
ProtKB P62937), CHCHD4 (UniProtKB Q8N4Q1), and
Histone H2AX (UniProtKB P16104) were synthetized with
a cleavable N-terminal His6-tag (CACCAT) and codon opti-
mized for Escherichia coli expression by GenScript®. The
coding sequences were subcloned into the pET28a expression
vector between two restriction sites: NdeI-NotI for CypA and
CHCHD4 and NcoI-NdeI for H2AX. The resulting con-
structs were used to transform the E. coli C41 (DE3) strain
for heterologous protein expression. Proteins were expressed
and purified as described in the supplementary materials.
2.2. Molecular Weight Determination by Size Exclusion
Chromatography. The hAIFΔ1-101 variants, either in the pres-
ence or absence of a 10-fold excess of NADH, were loaded
onto a HiPrep 26/60 Sephacryl™S-200 High Resolution (GE
Healthcare, Chicago, IL) column attached to a fast pressure
liquid chromatographic system (GE Healthcare, Chicago,
IL). Protein elution was performed in 50mM phosphate
buffer, 150mM NaCl, pH7.4, at a flow rate of 0.5mL/min.
The column was previously calibrated with the GE Health-
care LMW calibration kit (6 proteins in the 6400-
160000Da range). The obtained chromatograms were fitted
to a set of Gaussian functions.
2.3. Stabilization of Cross-Linked Protein Oligomers and
Electrophoretic Analysis. Reaction mixtures containing 4μM
of the hAIFΔ1-101 variants in 10mM phosphate, pH7.4 were
incubated with a 100-fold excess of the homobifunctional-
bis[sulfosuccinimidyl]-suberate (BS3) (Pierce) cross-linker
at room temperature in the absence or presence of a 10-fold
excess of NADH. Reactions were stopped by the addition of
the denaturing bromophenol blue sample buffer and heated
5min at 95°C. Sample mixtures were then resolved by 12%
SDS-PAGE.
2.4. Spectroscopic Characterization. UV-visible spectra were
recorded in a Cary 100 Bio spectrophotometer (Agilent,
Santa Clara, CA). Protein concentrations were determined
using the molar absorption coefficients of each variant, which
were estimated by protein denaturation with 3M guanidi-
nium chloride in 10mM phosphate, pH7.4, followed by
quantification of the released FAD. The extinction coeffi-
cients for WT, W196A, W196L, and W196Y hAIFΔ1-101ox
were ε451nm = 13:7M−1 cm−1 [10], ε451nm = 13:35M−1 cm−1,
ε451nm = 13:92M−1 cm−1, and ε452nm = 14:01M−1 cm−1
respectively. Circular dichroism (CD) spectra were recorded
in a thermostated Chirascan (Applied Photophysics Ltd., Sur-
rey, UK). Far-UV CD spectra were acquired using 1μM pro-
tein in a 0.1 cm pathlength cuvette, while near-UV/Vis CD
spectra were recorded using 20μM protein in a 1 cm path-
length cuvette. Fluorescence spectra were recorded in a
thermostated Cary Eclipse Fluorescence spectrophotometer
(Agilent, Santa Clara, CA) using 2μMprotein in a 1 cm path-
length cuvette. Flavin fluorescence emission spectra were
acquired in the 480-600nm range upon excitation at
450 nm. Fluorescence emission spectra of aromatic residues
were collected from 300 to 550nm upon excitation at
280 nm. CD and fluorescence spectra were recorded in the
absence and presence of a 100-fold excess of NADH at






Figure 1: Comparative overview of the crystallographic structures of WT hAIFΔ1-101ox (PDB 4BV6), WT CTC hAIFΔ1-101rd:2NAD(
+/H)
(PDB 4BUR), and W196Aox variant (PDB 5KVH). (a) Cartoon superposition. FAD-, NADH-, and C-terminal domains colored in gold,
light blue, and pale green, respectively. FAD drawn as sticks with C atoms in yellow, salmon, and magenta, respectively, for WTox, WT
CTC, and W196Aox structures. Visible residues in the β-hairpin and the regulatory 509-560 C-loop are shown in red, magenta, and
salmon, respectively, for WTox, WT CTC, and W196Aox structures. Missing fragments of the C-loop (P545-D559, K518-G557 and A511-
D559 in WTox chain A, WT CTC chain C, and W196Aox chain A structures, respectively) are indicated as dashed lines. Detail of the
W196Aox NADHA binding site overlaid with (b) WTox and (c) WT CTC. Detail of the W196Aox NADHB binding site overlaid with (d)
WTox and (e) WT CTC. Side chains for relevant residues are shown as CPK colored sticks with C atoms in salmon for W196Aox and in
light grey for WTox and WT CTC structures. NAD(
+/H)A and NADHB in the WT CTC structure are shown as CPK colored sticks with its
C atoms in blue.
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2.5. Thermal Denaturation Assays. Thermal denaturation
curves were followed by changes in the FAD fluorescence
emission upon its release from the protein by sample excita-
tion at 450nm. Curves were monitored from 10 °C to 90 °C
with scan rates of 1°C/min, both in the absence and presence
of a 100-fold excess of NADH. The curves for each variant
were roughly normalized to values between 0 and 1 and glob-
ally fitted to a two-step process describing a single transition
unfolding equilibrium (native (N)↔unfolded (U)) by using
the following equation [23]:
Sobs =
SN +mNT + SU +mUTð Þe− ΔG/RTð Þ
1 + e− ΔG/RTð Þ
, ð1Þ
in which Sobs is the measured protein signal at a given tem-
perature (T). SN and SU are intercept at 0K with the y-axis
of the linear extrapolation for the native and unfolded pre-
and posttransition regions, respectively, while mN and mU
are the corresponding slopes. The stabilization Gibbs energy
depends on temperature according to ΔG = ΔHð1 − 1/TmÞ
+ ΔCPðT − Tm − T ln ðT/TmÞÞ, where ΔH is the unfolding
enthalpy, Tm is the midtransition temperature, ΔCP is the
unfolding heat capacity change, and R is the ideal gas
constant.
2.6. Kinetics Measurements. The steady-state diaphorase
activity of hAIFΔ1-101 variants was measured in air saturated
50mM potassium phosphate, pH8.0, using NADH as the
substrate donor and 95μM dichlorophenolindophenol
(DCPIP, Δε620nm = 21mM−1 cm−1) as acceptor [10]. When
saturation profiles on the pyridine nucleotide concentration
were observed, kinetic constants were estimated by fitting
initial reaction rates at different coenzyme concentrations











1 + kcat/KNADHm NADH½ /kcat
  ,
ð2Þ
where v stands for the initial velocity, e is the enzyme concen-
tration, KNADHm is the Michaelis constant for the enzyme-
NADH complex, kcat is the turnover number of the enzyme,
and kcat/KNADHm is the enzyme catalytic efficiency.
The reactivity of the CTC towards molecular oxygen was
monitored by full reduction of hAIFΔ1-101 samples with
NADH (1.5-fold the concentration of the protein) in 50
mM phosphate buffer, pH 7.4, and following their reoxida-
tion in a Cary 100 spectrophotometer (Agilent, Santa Clara,
CA). Absorption spectra were recorded at 25 °C until full oxi-
dation of the flavin cofactor was achieved. For each time, the
percent remaining of CTC versus reoxidation by molecular
oxygen was estimated as ΔAt/ΔAmax, where ΔAmax is the dif-
ference between the minimum and the maximum absor-
bance at 700 nm, and ΔAt is the difference of each value at
700nm minus the minimum absorbance at 700 nm. The
CTC half-life is the time at which 50% of CTC still remains.
A SX18.MV stopped-flow spectrophotometer (Applied
Photophysics Ltd., Surrey, UK), interfaced with the
ProData-SX software and a photodiode array detector, was
used to investigate the fast kinetic reduction of the hAIF var-
iants by the NADH coenzyme. Samples of ~10 μM hAIFΔ1-
101ox were mixed with increasing concentrations of NADH
(0.03-10 mM) under aerobic conditions in 50 mM potassium
phosphate, pH 7.4, at 25 °C. The enzyme and NADH concen-
trations are the final ones obtained after mixing equal vol-
umes of substrate and enzyme. Observed rate constants for
the hydride transfer (HT) event (kobs) were calculated by
global analysis and numerical integration methods (simulta-
neously using all spectral data in the 400-800 nm region
along time evolution). A single-step model (A→B) best fitted
to describe the overall reaction at all NADH concentrations
assayed. Averaged kobs values at each NADH concentration
were then fitted to the equation that describes the formation





where kHT is the limiting rate constant for HT from the pyr-
idine nucleotide coenzyme to the FAD cofactor of hAIF,
KNADHd is the dissociation constant of the transient hAIFΔ1-
101ox:NADH complex, and krev is the reaction constant for a
potential overall reverse process.
Stopped-flow spectrophotometry was also used to evalu-
ate the rate constants of CTC formation when mixing photo-
reduced hAIFΔ1-101 (hAIFΔ1-101phrd) with increasing
concentrations of NAD+ (0.125-5mM) under anaerobic con-
ditions. hAIFΔ1-101phrd samples were obtained by photore-
duction in the presence of 5μM methyl viologen, 3μM 5-
deazariboflavin, and 20mM EDTA. The assays were per-
formed at 25 °C in 50mM potassium phosphate, pH7.4,
under anaerobic conditions (obtained by several cycles of
vacuum application and bubbling with O2 free argon). Data
were global fitted to a single step model (A→B), and kobs were
determined at the different NAD+ concentrations assayed.
These values were then fitted to the equation that describes
the formation of a transient hAIFΔ1-101phrd:NAD
+ complex
prior to the CTC stabilization:
kobs =
kCTC NAD+½ 
KNAD+d + NAD+½ 
, ð4Þ
in which kCTC is the limiting rate constant for the rearrange-
ment of the encounter complex to form the CTC, and KNAD+d
is the dissociation constant for the mentioned transient
encounter complex.
2.7. Isothermal Titration Calorimetry (ITC). ITC assays were
carried out using an Auto-iTC200 (MicroCal,Malvern-Pana-
lytical, Malvern, UK) thermostated at 25 °C. Typically, 10-
20μM protein partner and dsDNA samples—prepared as
described below—were used to titrate ~10μM hAIFΔ1-101
variants. All solutions were degassed at 15°C for 1min before
each assay. A sequence of 2μL injections of titrant solution
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every 150 s was programmed, and the stirring speed was set
to 750 rpm. The association constant (Ka), the enthalpy of
binding (ΔH), and the binding stoichiometry (N) were esti-
mated through nonlinear least-squares regression of the
experimental data employing a single-ligand binding site
model implemented in Origin 7.0 (OriginLab, Northampton,
MA). The dissociation constant (Kd), the free energy change
(ΔG), and the entropy change (ΔS) were obtained from basic
thermodynamic relationships.
Since hAIF binds DNA unspecifically, a 0.5mM dsDNA
sample was prepared from 1mM solutions of HPLC-
purified forward and a reverse complementary 15-bp oligo-
nucleotides (5′- GGT TAG TTA TGC GCG -3′; randomly
designed) synthetized by Integrated DNA Technologies.
The pair of oligonucleotides was mixed at an equimolar ratio
and annealed by heating 1min at 99°C and performing a 3 h
temperature scanning from 95 to 25°C, decreasing 1°C each
3min. 0.5mM dsDNA stock solutions were obtained.
2.8. Generation of Structural Models. Models containing the
missing C-loop residues (546–558 and 518-559, respectively,
for crystal structures of WT hAIFΔ1-101ox and hAIFΔ1-
101rd:NAD
+ states), as well as W196A, W196L, and W196Y
mutations, were built using as templates, the coordinates of
WT hAIFΔ1-101ox (PDB 4BV6) and hAIFΔ1-101rd:NAD
+
(PDB 4BUR) and the Swiss-Model server [7, 10, 24]. Rou-
tines for minimization and molecular dynamics (MD) simu-
lations followed previous reported protocols [7] and are
summarized in the supplementary materials. Improvements
include using a time step of 2 fs and performing five replicas
of 10 ns MD production for each model structure.
2.9. Data Analysis. Data were fit and shown using SigmaPlot
(Systat. Software Inc. Richmond, CA, USA), Origin 7.0 (Ori-
ginLab Corporation, Northampton, MA), and Pro-K
(Applied Photophysics Ltd., Surrey, UK). VMD [25] and
PyMol [26] were used to analyze and visualize structural
data, as well as to produce structural figures.
3. Results and Discussion
3.1. Mutations at W196 Residue Hardly Impacts the Overall
hAIFΔ1-101 Core Conformational Properties in Oxidized and
NADH-Reduced States. The threeW196 variants here studied
were purified to homogeneity as holoproteins after their
expression in E.coli as described previously for the WT pro-
tein [10]. Their UV-visible absorption spectra showed the
characteristic bands I and II of the flavin at 451 and
380nm, respectively, a shoulder at 476nm, and A280/A451
ratio ≈11, indicating that, similarly to the WT protein, the
cofactor was in the oxidized state and correctly incorporated
to the protein (Figure S2A). Only W196A showed a distorted
shape for band II and lower A451/A380 ratio reflecting some
differences in the environment of its flavin ring.
TheW196 variants also had similar far-UV CD spectra to
the WT protein, with minima at ~222 and ~208 nm indica-
tive of high α-helix content (Figure S2B). Reduction of the
FAD cofactor by NADH produced the decrease in relative
intensity of minima at 208nm for all mutants (Figure S2C),
as previously reported for the WT protein [7]. This suggests
similar overall conformations in the CTCs. The near-
UV/Vis CD spectra of the variants showed the WT
characteristic maxima (~300nm and ~365nm) and minima
(~453 and ~477 nm) (Figure S2D). Finally, changes
observed upon incubation with NADH were also consistent
with FAD reduction (lack of near-UV CD signal at 300nm
and in the 350-500 nm range) and CTC stabilization (new
minima at ~405nm and broad bands at ~600 nm) in all
variants (Figure S2E) [7].
Since the crystal structure is only available for W196Aox,
we built structural models containing the W196 mutations,
as well as the missed C-loop residues in the WT X-ray struc-
tures, to further evaluate the impact of mutations on the con-
formation of hAIFΔ1-101ox and its CTC [7, 10]. Models for
oxidized variants, including W196Aox, were built using the
WTox crystal structure as a template to better evaluate the
effect of each mutation on native structures, thus preventing
the other variant’s models from being “forced” to behave as
W196Aox. After 10ns MD relaxation, only small fluctuations
within each simulated system were detected for averaged
values of energy, radius of gyration, RMSD, and solvent
accessible surface (SAS) of ligands, as well as for the main
interactions coupling the FAD cofactor and NADH coen-
zyme to the protein (Figures S3A and S4). These
observations contrast with those obtained when similarly
evaluating the pathogenic deletion of residue R201 situated
together with W196 in the β-hairpin and also contributing
to C-loop linking [7]. This clinical ΔR201 variant rapidly
breaks the network linking the FAD cofactor, the β-hairpin
itself, the active site residues, the central β-strand, and the
C-loop during the MD production [7]. Altogether,
experimental and modelling evidences indicate that
substitutions at W196 retain the WT hAIFΔ1-101
architecture at the active site and the protein core, in both
the oxidized and CTC states. In agreement, W196Aox was
even able to crystallize [11].
3.2. W196 Side Chain Modulates the Monomer-Dimer
Equilibrium in hAIFΔ1−101. Gel filtration chromatography
was used to study the impact of mutations on the ability of
hAIFΔ1−101 to undergo NADH-linked dimerization. While,
similarly to the WTox protein (Figure 2(a)) [10], the
W196Yox mutant eluted as a monomer of apparent molecu-
lar weight (appMW) ~45-58 kDa (Figure 2(b)), the W196Lox
and W196Aox variants eluted as considerably broad peaks
with lower exclusion volumes. Peak deconvolution suggested
two populations with appMW of 63 and 115 kDa forW196Lox
and 75 and 138 kDa for W196Aox (Figures 2(c) and 2(d),
respectively), indicating less compact monomeric conforma-
tions and/or a quick monomer-dimer exchange. Upon incu-
bation with NADH, the W196Y and W196L variants eluted
mainly as a new peak of lower exclusion volume (~145-
155 kDa) (Figures 2(b) and 2(c)) that was previously related
to the CTC dimer in the WT protein (Figure 2(a)). Finally,
the elution peak for W196A in the presence of NADH, when
compared to W196Aox, also gets narrower and slightly dis-
placed towards the WT CTC dimer elution volume
(Figure 2(d)).
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Chemical cross-linking with BS3—able to covalently con-
jugate hAIF dimers but not monomers—followed by assess-
ment of species by SDS-PAGE (Figure 2(e)), was then used
to evaluate whether the observed chromatographic changes
might relate toW196 mutations influencing the compactness
of protein conformation and/or the CTC dimer lifetime.
Upon incubation with BS3, all oxidized mutants exhibited
the band of ∼55 kDa corresponding to the hAIFΔ1−101ox
monomer, although it was in general more diffuse than in
the cross-linker absence. When variants were preincubated
with both NADH and BS3, an additional broad band of
~170 kDa was detected. In WT hAIFΔ1−101, this band is
related to the protein ability to undergo dimerization in the
CTC state upon NADH binding and flavin reduction [10].
Noticeably, this band, indicative of dimer stabilization, was
also observed for W196Aox (in the absence of the coenzyme),
in agreement with the exclusion chromatography data
obtained for this variant (Figure 2(d)) and with its reported
dimeric crystal structure [11]. These data confirm that all
W196 variants are able to dimerize upon NADH reduction,
but also show that the mutations modulate the CTC dimer
stability. They also suggest conformational changes that
favor the displacement of the monomer-dimer equilibrium
towards the dimer in the oxidized state, particularly in
W196Aox.
3.3. W196 Highly Contributes to Modulate the Low Efficiency
of hAIFΔ1-101 as NADH Oxidase. Under physiological
Elution volume (mL)

























































Figure 2: Effect of W196 replacement on the hAIFΔ1-101 ability to stabilize dimers. Elution profile of (a) WT, (b) W196Y, (c) W196L, and (d)
W196A on a Sephadex S-200 column at 6°C. The assays were performed in absence and presence of a 10-fold excess of NADH, and profiles
are, respectively, shown in black continuous and dashed lines. The respective different populations assigned by Gaussian analysis are depicted
in grey lines. (e) Chemical cross-linking of hAIFΔ1-101 samples (~3 μM proteins) with a 100-fold excess of the BS
3 cross-linker in the absence
and presence of NADH (300 μM). After 45 minutes of incubation, the reactions were stopped by the addition of bromophenol sample buffer
and resolved by 12% SDS-PAGE.
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conditions, hAIF exhibits a NADH oxidase activity that can
be in vitro monitored using the steady-state DCPIP-
dependent diaphorase reaction. When evaluated in this
way, all W196 variants showed higher turnover rates than
the WT protein (~3-fold increase for W196Y and W196L
and ~5-fold for W196A) (Table 1). Regarding KmNADH, the
W196Y variant value was similar to that for the WT, while
the W196L and W196A variants showed a significant
decrease (~3- and 10-fold, respectively). Thus, W196Y,
W196L, and W196A variants were ~3, ~8, and~45 times
more efficient oxidizing NADH than the WT protein. None-
theless, despite these W196 variants are more efficient as oxi-
doreductases than WT hAIFΔ1−101, they were unable to
oxidize NADH when using molecular oxygen as electron
acceptor, analogously to the WT protein [10]. In the light
of these results, we studied the impact of theW196mutations
on the HT reaction from NADH to the FAD cofactor of
hAIFΔ1-101 by using stopped-flow transient kinetics. The
kinetic traces recorded for all variants at different NADH
concentrations indicated an essentially irreversible two-
electron reduction of the FAD cofactor and the concomitant
formation of a long wavelength broad band related to the sta-
bilization of the hAIFΔ1-101rd:NAD
+ CTC species (Figure 3
and S5). The intensity of this CTC band (area in the 510
−800nm region minus that of the free protein) for W196A
and W196Y variants was in the range of that observed for
the WT [10], suggesting similar percentage of CTC stabiliza-
tion. However, the lower intensity of W196L CTC band
(∼76%) indicates either different charge distribution between
coenzyme and FAD rings in the CTC (suggestive of different
CTC geometry) or reduction of the amount of the CTC sta-
bilized. In all cases, global analyses of the spectral range time
evolutions best fitted to a one-step model (A→B). Thus, the
observed processes appeared including the fast formation of
the transient hAIFΔ1-101:NADH reactive complex followed
by the HT reaction and the CTC formation (Scheme 1). As
a consequence, the conformational switches in β-hairpin
and C-loop induce protein dimerization in W196 variants,
with the potential exception of W196A that presumably
might be mostly a dimer with the C-loop already released
in the oxidized state [11]. The kobs values obtained showed
hyperbolic dependence on NADH concentration for all var-
iants, allowing kHT and Kd
NADH determination upon fitting
to the equation (4) (Figure 3(e) and Table 1). All variants
showed faster HT rate constants and higher affinity for the
NADH substrate than the WT protein (up to ~29- and 5-
fold, respectively, for W196A). Consequently, W196Y,
W196L, and W196A were ~12-, ~24-, and up to ~153-fold
more efficient than the WT enzyme as hydride acceptors
from NADH. Noticeably, and, contrary to that described
for the WT protein, all these W196 variants showed kHT
values higher than their turnover rates, suggesting that for
them, the HT reaction is not the limiting step during cataly-
sis. Therefore, the W196 side chain highly contributes to
modulate the properties of hAIFΔ1-101 as a nonefficient
NADH oxidase.
Structurally, W196 does not form part of the protein
redox active site itself. However, W196 side chain stacks to
P488 at the edge of the central β-strand, contributing to situ-
ate the β-hairpin and the C-loop forming a cavity at the bot-
tom of which sitsW483—a residue that flanks the pyrimidine
ring of FAD—(Figure 1(b)). W196A mutation increases
W483 solvent accessibility and C-loop and β-hairpin flexibil-
ity, favoring their displacement from the WTox positions
(Figures 1(c)–1(e) and 4). Noticeably, we observed the β-
hairpin displacement from P488 as well as the central β-
strand retraction from the beginning of our W196Aox model
MD trajectories (starting fromWTox structure) (Figure 5(a)).
However, the Y196 and L196 side chains contribute to main-
tain β-hairpin position in the W196Yox and W196Lox trajec-
tories, and retraction of the central β-strand is hardly
deduced for W196Lox (Figure 5(a)). Trajectories also show
a larger increase in the SAS of the β-hairpin of W196Aox rel-
ative to the other two variants and the WT (Figure S3B).
Thus, MD simulations predict an increase in distances
between W483 and atomic positions at the active site of the
oxidized variants (Figure S4A). Such changes in W483
solvent accessibility and active site compression must
impact substrate affinity and coupling into a competent
complex for HT, as well as the FAD midpoint reduction
potential and/or electronic distribution—as was previously
reported for the murine W196A variant (70mV higher
redox potential than those for the WT protein)—[9]. In
agreement, kinetic parameters show W196A as the variant
differing more from the WT behavior regarding efficiency
for both HT and NADH binding, followed—by far—by
W196L and being the aromatic substitution the one
producing a milder effect. Dynamics of active site in CTCs
show higher flexibility regarding oxidized state
(Figure S4A-B), but WT CTC keeps its characteristic






















WT 0:9 ± 0:1 495 ± 170 1:9 ± 0:9 1:5 ± 0:1 4090 ± 300 0:4 ± 0:1 45 ± 2 2080 ± 250 22 ± 3
W196Y 2:7 ± 0:1 505 ± 35 5:3 ± 0:6 12 ± 1 2870 ± 320 4:0 ± 0:8 16 ± 1 183 ± 27 87 ± 14
W196L 2:8 ± 0:1 187 ± 18 15 ± 1:9 36 ± 1 1725 ± 210 21 ± 3 29 ± 2 433 ± 11 67 ± 18
W196A 4:3 ± 0:2 25 ± 4 172 ± 35 126 ± 1 1070 ± 40 117 ± 5:3 30 ± 1 394 ± 50 76 ± 10
Assays were performed at 25°C in 50mM potassium phosphate, pH 7.4 (n = 3, mean ± SD). 1Kinetic parameters for CTC formations were obtained with
hAIFΔ1-101phrd variants.
8 Oxidative Medicine and Cellular Longevity

































































































































































Figure 3: Kinetic characterization of W196 hAIFΔ1-101 variants. Spectral evolution of the reduction of (a) WT (~10μM) and (b) W196A
variant (~ 10μM) when mixed with NADH (2 and 5mM for WT and W196A, respectively). Spectra for the reduction of WTox are shown
at 0.15, 1.05, 2.1, 4.2, 6, 10.05, 12.45, 20.1, 30, 40.05, and 50.1 s after mixing and those for W196A at 0.005, 0.05, 0.1, 0.15, 0.2, 0.25, 0.3,
0.45, 0.5, and 0.55 s. Dotted lines correspond to the spectra of oxidized enzymes before mixing with the coenzyme. The corresponding
insets show the absorbance spectra for the intermediate species obtained by fitting the spectral evolution to a single step model (A→B)
and the evolution of the concentration of each species. Kinetics of CTC formation upon mixing of the hAIFΔ1-101phrd forms of (c) WT and
(d) its W196A variant with NAD+ (5mM) under anaerobic conditions. Spectral evolution for CTC formation of WT at 0.001, 0.005, 0.01,
0.015, 0.02, 0.07, 0.1, 0.15, 0.2, 0.33, 0.4, and 0.5 s after mixing and those for W196A at 0.001, 0.002, 0.005, 0.006, 0.007, 0.008, 0.009, 0.01,
0.03, 0.05, 0.07, 0.09, 0.1, 0.3, and 0.5 s. The corresponding insets show the absorption evolution at 750 nm (black circle) and the fits
(continuous line) at this wavelength after globally fitting evolution at a single step model (A→B). (e) Dependence of the observed rate
constants for flavin reduction for the WT (black circle), W196Y (black triangle), W196L (black diamond), and W196A (grey square)
reactions on the NADH concentration. Lines represent the fits of experimental data to equation (3). (f) Dependence of observed rate
constants for CTC formation when using WT (black circle), W196Y (black triangle), W196L (black diamond), and W196A (grey square)
hAIFΔ1-101phrd on the NAD
+ concentration. Lines represent the fit of experimental data to equation (4). Assays were performed in a
stopped-flow spectrophotometer in 50mM potassium phosphate, pH 7.4, and at 25°C (n = 3, mean ± SD).
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parallel ionic pair through stacking of the NAD+
nicotinamide and FADH- isoalloxazine reacting rings
(Figure S4D). In such arrangement, the angle formed
between the C4n hydride donor of the nicotinamide of the
coenzyme, the hydride to be transferred and the N5
acceptor atom of the FAD isolloxazine ring (C4n-hydride-
N5) appears far from collinearity, involving a large free
energy penalty for geometric deformations and partial loss
of the π stacking interaction to achieve the transition state
[27, 28]. Therefore, despite the C4n-N5 distance being
compatible with HT, the hydride shift can be quite
inefficient. This seems to be the situation for HT in WT,
showing inefficient kcat and kHT values for NADH
oxidation. Noticeably, MD simulations for the W196 CTC
variants suggest the distortion of the FADH-:NAD+ pair
and the pulling apart of C4n and N5 reacting atoms
(Figure S4C). This effect is observed in W196A and W196L
CTCs and to a lower extent in W196Y CTC, in agreement
with improvement in their kHT parameters. Therefore, the
size and aromaticity of the side chain of W196 in hAIFΔ1-
101 are key to fix the β-hairpin position and, despite not
forming part of the active site itself, set the active site
geometry to make it a nonefficient NADH oxidase.
3.4. W196 Contributes to Stabilize the CTC State. Changes
above detected in Km
NADH and Kd
NADH envisage an impor-
tant impact of mutations at W196 on the association/disso-
ciation equilibria of NADH and NAD+ to hAIFΔ1-101.
Therefore, we proceeded to evaluate transient rate constants
for CTC formation as well as stability of the CTCs once
formed. To determine rate constants for CTC formation,
we mixed hAIFΔ1-101phrd samples with different concentra-
tions of NAD+ in the stopped-flow equipment (Figures 3(c)
and 3(d), and Figure S5). For all W196 variants, kinetic traces
showed CTC formation following an essentially irreversible
two-species process with kobs values showing hyperbolic
dependence on NAD+ concentration (Figure 3(f)). This
allows to determine Kd
NAD+ as well as the limiting kinetic
constant related to the establishment of the nicotinamide:i-
soalloxazine electronic exchange within the CTC species
(kCTC) (Table 1, Scheme 1). Mutations at W196 produce a
strong impact in Kd
NAD+, whose value decreases ~5-fold in
the Leu and Ala variants and up to ~11-fold in the Tyr one.
This indicates stronger affinity for NAD+ in the case of the
reduced mutants regarding the WT counterpart. On the con-
trary, the introduced mutations slightly decrease kCTC values
(up to less than 3-fold for W196Y). Therefore, W196 replace-
ment induces stronger affinity of hAIFΔ1-101phrd for NAD
+
relative to the oxidized state, but hardly influences the kinetic
evolution of the initial transient interacting complex to
achieve the final CTC conformation. These data indicate that
replacements at W196 kinetically favor CTC formation by




NAD+ values (Table 1), all W196
variants increase the thermodynamic preference for the
binding of NAD+ over that for NADH regarding the WT.
This agrees with the high impact of mutations on kHT becom-
ing considerably milder in kcat values, where release of the
NAD+ product will limit the overall oxidoreductase activity.
We then evaluated the mutational effect on reactivity
towards O2 for the CTC formed upon NADH oxidation. As
shown in Figure 6(a), the W196A CTC was highly stable ver-
sus reoxidation by O2, similarly to theWT CTC, (half-lives of
62 and 72min, respectively), while CTC lifetimes were
slightly shorter for W196Y and W196L (half-lives of 42 and
32min, respectively). Therefore, Tyr and Leu replacements
favor O2 access to the FAD cofactor in the CTC. Altogether,
these observations point to W196 and the β-hairpin confor-
mation also contributing to the strength of NADH/NAD+
binding to the hAIF active site.
3.5. W196Mutations Reduce Thermostability of hAIFΔ1−101ox,
but Not of the CTCs. Fluorescence emission curves reflecting
FAD release upon protein thermal denaturation were then
obtained to evaluate the effect of W196 substitution on
FAD binding and hAIFΔ1−101 stability (Figure 6(b) and
Table 2). All W196ox variants were less stable than WTox,
with TFADm dramatically decreasing between ~8 and ~11
°C.
Formation of the WT CTC upon NADH mixing has an even
more negative impact in WT hAIFΔ1−101 stability, decreasing
TFADm for the CTC (T
FAD
mCTC) by ~13
°C relative to TFADm [7].
This destabilizing effect was related to release of the regula-
tory C-loop in the hAIFΔ1−101 apoptotic domain promoting
looser tertiary structure contacts at the active site fostering
cofactor dissociation [7]. Interestingly, all reduced CTC var-
iants showed similar TFADmCTC to the WT CTC. This reflects
that CTC formation induces a considerably lower destabiliz-
ing effect in W196L and W196Y relative to their oxidized
states than in the WT case (TFADmCTC ~2 and ~6
°C lower than
their TFADm , respectively), while no destabilization is produced
at all for W196A. These data suggest that the decrease in
Scheme 1.
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compactness of the hAIFΔ1−101ox active site depends on
W196 mutation. In agreement, structural predictions indi-
cate that W196Aox has a larger propensity for β-hairpin
release, increasing of β-hairpin SAS as well as conforma-
tional rearrangement of the central β-strand and the loop
connecting it to the His-rich helix (Figure 5 and
Figure S3B). Thus, W196Aox backbone dynamics at these
regions envisages a behavior more similar to the CTC than
to WTox, while an intermediate situation appears for
W196Lox and W196Yox (Figures 5(c) and 5(d)). On this
side, the very low impact of mutations on TFADmCTC agrees
with conformational rearrangements already produced
upon CTC formation, having the W196 side chain less
relevance in contributing to the active site compactness.
Finally, since, according to the WT CTC crystal structure,

















































Figure 4: Impact of mutations on hAIFΔ1-101 flexibility. (a) B-factor putty representation of crystal structures of WT hAIFΔ1-101ox (4BV6),
WT CTC (4BUR), and W196A hAIFΔ1-101ox (5KVH) focusing in the environment of the β-hairpin containing residue 196 and the central
β-strand. Orange to red colors and a wider tube indicate regions with higher B-factors, whereas shades of blue and a narrower tube
indicate regions with lower B-factors. The FAD cofactor is shown as sphere representation with carbons in orange, while, when present,
the NAD+A and NADHB are shown as sticks with carbons in salmon and pink, respectively. (b) Heat map representation of the average
Cα root mean square fluctuation (RMSF) of five replicates for 10 ns MD simulations of the different W196 variants in both the hAIFΔ1-
101ox and CTC states. The region corresponding to the β-hairpin is highlighted with an orange square and that predicted for interaction of
CypA is indicated on the top of the panel.
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moiety of NADHB (Figure 1(e)), such lack of effect is
suggestive of NADHB binding being considerably weaker
than that of NADHA. This is clearly supported by the larger
SAS for NADHB over NADHA in the MD simulations,
which is in addition independent of the W196 variant
considered (Figure S3A). Therefore, these thermal stability
analyses suggest that mutations at W196 decrease the
compactness of hAIFΔ1−101ox. Noticeably, some of the
pathogenic mutations located at β-hairpin, such as ΔR201,
or involved in interaction between the β-hairpin and the
regulatory C-loop, such as F210S/L, are reported to also
show diminished compactness and/or stability [7, 29, 30].
3.6. W196 Contributes to Modulate the Conformation of the
Interaction Surfaces of hAIFΔ1−101 with Its Physiological
Partners. AIF plays a key role in cell death and life through
its interaction with nucleotides, but also with DNA and a
broad number of proteins. We selected some representative
ligands to evaluate the mutational effect ofW196 on the hAIF
interaction network: CHCHD4 as a mitochondrial partner
key in OXPHOS and energy homeostasis, as well as the
nuclease CypA and DNA as nuclear partners for chromati-
nolysis and PCD. We determined the binding parameters
that describe the formation of binary complexes using ITC
(Table 3, Figure 7 and S7). Due to the observed W196L ten-
dency to denature during ITC assays, these studies were
restricted to WT, W196A, and W196Y variants. For all
ligands, the binding isotherms adequately fitted to a model
of a single binding site with Kd in the micromolar range.
A number of evidences place CHCHD4 in the pathway
linking hAIF to the biogenesis of mitochondrial complexes
by facilitating the mitochondrial import of CHCHD4 and
its proper localization in IMS [12]. Nonetheless, heat
exchange was not observed when titrating WTox and
W196Yox with CHCHD4, resulting in binding thermogram
characteristic of noninteracting systems (not shown). In con-
trast, the titration of W196Aox with CHCHD4 revealed a
strong binding of CHCHD4 toW196Aox (Kd~0.4μM). Bind-
ing was entropically driven with the enthalpic contribution
being unfavorable (Figure 7(c) and S8A) and suggesting that
nonspecific forces contribute to this interaction. When we
analyzed the interaction of all CTC variants—obtained by
preincubation with NADH—with CHCHD4 (Figure 7 and
S8A), binding was detected, in agreement with previous stud-
ies that described such interaction as NADH dependent [13].
The WT CTC:CHCHD4 interaction was driven by a large
favorable enthalpic contribution indicative of specific bind-
ing, while the entropic contribution was unfavorable. This
suggests a structurally more organized complex than its sep-
arated protein components. W196Y CTC and W196A CTC
showed a thermodynamic profile similar to that of WT
CTC, but the mutations decreased the magnitude of the
favorable enthalpic contribution to the binding and made
the entropic term considerably less and slightly more unfa-
vorable, respectively. Regarding CHCHD4 affinity, no signif-
icant effect was produced by the alanine substitution in both
redox states relative to WT CTC, but the W196Y CTC signif-
icantly decreased it (Kd~10-fold higher). Structurally,
W196Aox in solution appears to be mainly a dimer with a dis-
ordered C-loop [11], sharing these features with WT CTC.
Thus, our data might support an essential role of the arrange-
ment of either the dimer conformation or the site exposed by
C-loop displacement or even the C-loop itself in the interac-
tion with CHCHD4. Such observations agree with deletion
mutants and pathogenic point mutations at the NADH




























Figure 5: Impact of W196 hAIFΔ1-101 mutations on the dynamics of the β-hairpin and its environment. Representative conformations of the
(a) β-hairpin and the central β-strand and the (b) His-rich helix and the loop connecting it to the central β-strand in final MD structures of
selected replicates for each W196ox variant. MD final replicates are shown in grey in each panel. All panels compare to the crystallographic
WTox structure (4BV6) that shows the β-hairpin in red, the C-loop in orange, and the rest of the protein in purple. Open green arrows
indicate relevant displacements of structural elements relative to the crystallographic WTox structure. The lower panel in (a) shows the
time evolution of the distances between Cαs of the residue at position 196 in the β-hairpin and P488 in the β-sheet. For each variant, data
show averaged values for the 5 MD replicates run for each model in the hAIFΔ1-101ox (bold lines) and CTC (line) states. Ramachandran
plots of the distribution of key main chain Φ/ψ conformational along the MD of selected replicates for each (c) oxidized and (d) reduced
W196 variant.
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and CTC structural rearrangements, consequently affecting
CHCHD4 binding and resulting in mitochondriopathy phe-
notypes [13, 31]. However, the W196Aox enthalpic/entropic
thermodynamic binding profile for CHCHD4 indicates non-
specific interactions, while those for CTCs suggest specific
organized interactions (Figure S8, Table 3). A defined
interacting region for CHCHD4 has not been identified yet
in hAIF, suggesting a relevant role for its entire ternary
organization. On the contrary, CHCHD4 binds through a
short N-terminal 27-amino-acid-long fragment, and its
redox state appears irrelevant for the interaction. Moreover,
this N-terminus is unstructured when CHCHD4 is free
[32], but appears to get a defined and organized structure
when interacting with the CTC [13]. This agrees with our
data that clearly indicates a specific CHCHD4 binding to
WT CTC. On the contrary, the thermodynamic parameters
here reported for CHCHD4 binding to W196Aox suggest
that, despite the conformational changes produced by the
mutation, CHCHD4 recognition is allowed and the
complex formed will be far from the specific interaction
presumably produced with WT CTC. Therefore, structural
NADH-dependent changes in AIF must play a key role in
the binding of CHCHD4. This is further supported by the
Tyr and Leu replacements in W196 also having a strong
impact in the specificity and organization of this




























Figure 6: Effect of W196 replacements on the CTC half-life and the thermal stability of hAIFΔ1-101. (a) Reactivity of the CTC towards O2 in
W196 hAIFΔ1-101 variants. hAIFΔ1-101rd:NAD
+ CTC decay was monitored at 750 nm and 25°C in air saturated 50mM potassium phosphate at
pH 7.4. CTC hAIFΔ1-101rd:NAD
+ samples were obtained by mixing hAIFΔ1-101ox variants with NADH (0.7-fold the enzyme concentration).
The traces for WT (black circle), W196Y (black triangle), W196L (black diamond), and W196A (grey square) hAIFΔ1-101 are shown
normalized from 1 to 0 as fraction of CTC remaining along the time. The solid line represents the fit of the traces to a single-exponential
decay process to determine CTC half-life. (b) The thermal stability for flavin release (Tm
FAD) of hAIFΔ1-101 variants. Curves for FAD
thermal release in oxidized variants (closed symbols) and its CTC state (open symbols), as monitored by increase in FAD fluorescence
emission upon protein denaturation. The WT, W196A, W196L, and W196Y hAIFΔ1-101 are in black circle, black square, black diamond,
and black triangle, respectively. The curves are roughly normalized to the change in fluorescence signal of the FAD bound fraction (PN ,
from 1 to 0), with their fits to a two-transition unfolding model (continuous and dashed lines for oxidized and reduced states,
respectively). Decrease in FAD bound fraction was experimentally followed by the increase in its fluorescence upon release from the
holoprotein along a 20 to 85°C temperature ramp. Data were obtained in 50mM potassium phosphate at pH 7.4 and at a final ionic
strength of 150mM. Protein concentration was ~2μM. The CTC forms were obtained by premixing hAIFΔ1-101ox and NADH at a 1 : 100
ratio.




















WT 337 ± 1 128 ± 3 – 324 ± 1 150 ± 4 – −13 ± 2
W196Y 329 ± 1 123 ± 3 −8 ± 2 323 ± 1 167 ± 4 −1 ± 2 −6 ± 2
W196L 326 ± 1 118 ± 3 −11 ± 2 324 ± 1 159 ± 4 0 −2 ± 2
W196A 326 ± 1 103 ± 3 −11 ± 2 326 ± 1 170 ± 4 2 ± 2 0
Values obtained by fitting fluorescence thermal denaturation curves to a two-state unfolding model. Data obtained in 50mM potassium phosphate, pH 7.4, at a
final ionic strength of 150mM, from 283.15 to 363.15 K. Protein concentrations was ~2 μM, and NADH concentration was in 100-fold excess (n = 3,
mean ± SD).
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the competent interaction of hAIF with CHCHD4 relies on
the adequate CTC architecture to favor the assembly of
potentially disordered regions from both proteins to
achieve a specific conformation. (ii) W196 contributes to
provide such CTC architecture, by potentially regulating
the proper β-hairpin configuration that is key for the
structural transition of hAIF and its role in mitochondrial
homeostasis. In agreement, a nonproductive interaction
between hAIF and CHCHD4 has been suggested for the
clinical mutation F210L that results in abnormal assembly
of mitochondrial complexes I and III [30].
Parameters for the titration ofWTox with CypA indicated
the enthalpically driven formation of a binary complex with
unfavorable entropic binding contribution (Table 3,
Figures S7A and S8B). This agrees with the large number of
electrostatic contacts reported for the CypA interaction
with the AIF synthetic peptide (370-394) [33–35], as well as
with the complex adopting a large complementarity of the
two proteins. Noticeably, the enthalpic contribution to the
CypA binding turned into unfavorable for W196Yox and
W196Aox (Table 3, Figures S7B-C and S8B). However, this
is compensated by a change in the sign of the binding
entropic contribution that became highly favorable and
made the mutational effect being insignificant regarding
overall affinity (enthalpy-entropy compensation).
Nevertheless, the mutational switch in thermodynamic
contributions to the hAIF:CypA interaction suggests
specificity decrease and production of nonnative-like
conformations. This is interesting, because W196 and the
β-hairpin do not share the protein surface with the AIF
NADH domain where the 370-394 β-strand (binding spot
for CypA) is situated (Figures S8E and S9). Nonetheless,
replacements at W196 have important effects in hAIFΔ1
−101ox stability (Table 2), as well as in the conformation of
the C-loop, the central β-strand, and the dimerization
interface located far away from W196. Therefore,
conformational changes occurring in the β-hairpin might
be also transmitted to the CypA binding site identified in
hAIF. These conformational changes on one side might
hinder charge contacts of the 370-394 β-strand to CypA,
while on the other they might favor CypA binding to hAIF
by C-loop structural transition towards a more organized
and favorable conformation as indicated by the entropy
becoming favorable. In agreement, reduction of the
flexibility of a stapled hAIF (370-394) peptide analogue
constructed to stabilize its β-strand organization as in hAIF
considerably improved its affinity for CypA [35]. Therefore,
the higher specificity of WTox for CypA versus the W196ox
variants might derive from its increased conformational
rigidity favoring a lock-and-key mechanism of recognition,
while increasing protein flexibility turns into an unspecific
interaction.
Finally, positive charges clustered along the AIF surface
are likely to contribute to DNA binding, but a clear sequence
specificity is not expected since AIF recognizes DNA and
RNA, as well as a large panel of ribonucleoproteins [36]. Our
thermograms for WTox titration with dsDNA further confirm
such lack of specificity, since they show an entropically driven
binding with an unfavorable enthalpy contributing to the
interaction (Figures S7D and S8C, Table 3). W196A and
W196Y mutations hardly impair the hAIFΔ1−101ox affinity
for DNA in binary complexes (Kd values~4-fold higher than
WT). However, although thermodynamic patterns
resembled the WT ones, the entropic and enthalpic binding
contributions for W196A and W196Y variants were more
favorable and less unfavorable, respectively (Figures S7E-F
and S8C, Table 3). Structurally, binding of DNA to hAIFox is
proposed to occur through the nucleotide strand wrapping
around a positively charged protein crown. This crown
appears considerably modulated in shape as well as in
accessibility when comparing crystallographic WTox to
W196Aox structure as well as in MD models for all variants
(Figure S9), in agreement with the modulation observed in
experimental binding parameters.
Altogether, these results show that the W196 side chain
influences the enthalpic and entropic contributions to the
Table 3: Thermodynamic parameters for the binary interaction of hAIFΔ1-101 variants with CHCHD4, CypA, and DNA.
hAIFΔ1-101 form Titrating ligand Kd (μM) ΔH (kcal/mol) ΔG (kcal/mol) - TΔS (kcal/mol)
WTox and W196Yox CHCHD4 No detected binding
W196Aox CHCHD4 0.4 9.6 -8.4 -18.0
WT CTC CHCHD4 0.2 -20.1 -8.7 11.4
W196Y CTC CHCHD4 2.1 -8.2 -7.5 0.7
W196A CTC CHCHD4 0.5 -5.9 -8.3 14.2
WTox CypA 2.7 -24.5 -7.3 17.2
W196Yox CypA 1.0 17.0 -7.9 -24.9
W196Aox CypA 1.8 27.3 -7.6 -34.9
WTox dsDNA 1.6 4.8 -7.6 -12.4
W196Yox dsDNA 6.9 19.2 -6.8 -26.0
W196Aox dsDNA 5.8 15.0 -6.9 -22.0
Values obtained from ITC assays at 25°C in 50mM potassium phosphate, pH 7.4. n is the calculated biding stoichiometry. The thermodynamic parameters were
calculated by Kd = ðKaÞ−1, ΔG = RT:ln Kd , and −TΔS = ΔG − ΔH. Errors considered in the measured parameters (±20% in Kd and ±0.3 kcal/mol in ΔH and
−TΔS) were taken larger than the standard deviation between replicates and the numerical error after the fitting analysis.
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Figure 7: Effect of theW196 replacement in the binding of CHCHD4 to hAIFΔ1-101. Calorimetric titrations of (a) WT CTC, (b)W196Y CTC,
(c) W196Aox, and (d) W196A CTC with CHCHD4. The upper plots show the thermograms (thermal power as a function of time), whereas
the lower plots show the binding isotherm (normalized heats as a function of the CHCHD4/hAIF molar ratio). Measurements were carried
out in 50mM potassium phosphate, pH 7.4, at 25°C. The CTC forms were obtained by premixing hAIFΔ1-101ox and NADH at a 1 : 100 ratio.
The binding parameters were estimated through nonlinear least-squares regression applying a single-ligand binding model (continuous lines
in binding isotherms).
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free energy of hAIF binding in binary complexes with
CHCHD4, CypA, and DNA. Whereas, its replacement has
in general a negative impact on the enthalpic binding contri-
bution, while improves the entropic one (with the only
exception of W196A CTC:CHCHD4 complex). Therefore,
W196 contributes to stabilize the conformation of the inter-
action surfaces of hAIF with CHCHD4, CypA, and DNA.
3.7. W196 Contributes to Control the hAIF Conformational
Landscape to Adapt to Its Physiological Roles. AIF is a moon-
light protein with functions in the mitochondria, cytosol, and
nucleus, where it appears to behave as a redox sensor of
NAD(H/+) cellular levels [9–11]. The cellular redox state
(NAD+/NADH ratio) may modulate the AIF conformational
landscape regarding both overall protein conformation and
quaternary organization, which in turn seems to be critical
for establishing its biomolecular interaction network. The
regulatory C-loop in AIF is a predicted internally disordered
region that tends to adopt an organized conformation in the
protein oxidized state (Figure 1, Figure S8 and S9), but that is
released upon NADH-dependent protein reduction, CTC
formation, and protein dimerization. The structural
properties of W196Aox suggested that the W196 side chain
and the β-hairpin coupling to the C-loop are key to
modulate the structural transition of hAIF in a cellular
context.
In healthy mitochondria, hAIF is present in a monomer-
dimer equilibrium—regulated by the cytoplasmic NADH
pools—that modulates its participation in respiratory com-
plex assembly by physical interactions with CHCHD4 [10,
12–14]. This AIF switching may be critical for maintaining
mitochondrial homeostasis along changes in NAD+/NADH
ratios in response to diet, diseases such as neurodegenerative
disorders, and other processes associated to NAD-
consuming enzymes—particularly PARP-1 whose activity is
increased during aging due to DNA damage accumula-
tion—[37, 38]. In response to NAD+ depletion by hyperstim-
ulation of PARP-1, hAIF is released from the mitochondria
to the cytosol, allowing its translocation to the nucleus and
promoting parthanatos cell death. PARP-1 binding to AIF
has been proved to mediate its release from IM by likely
inducing conformational changes in the protein [39]. Curi-
ously, the expression levels of AIF were found to be gradually
decreased during development and growth in spiral ganglion
neurons involved in auditory neuropathy spectrum disorder,
a disease caused by point mutations in hAIF, while increased
in the aging-related cell dysfunctions where the hAIF role as
apoptosis inducer might be more important [40]. To investi-
gate the different potential roles of AIF during development
and aging and their regulatory mechanisms, future studies
will be required.
In the last years, a significant number of rare mitochon-
drial diseases caused by more than 20 point mutations in
the AIFM1 gene have been identified. Some mutations in
the cell death domain give rise to phenotypes with progres-
sive disorders from childhood, as the Cowchock syndrome.
On their side, mutations affecting the hAIF reductase proper-
ties decrease the content of respiratory complexes and pro-
duce cell respiration deficiencies, while some of them
prevent in addition the correct folding of the protein by
decreasing its conformational stability. In this later case, the
search of molecular chaperones represents an alternative
therapeutic strategy yet poorly explored [7, 31, 41–44]. These
mutations produce serious mitochondrial encephalopathies,
in many cases with severe processes of neurodegeneration
and early death. Noticeably, all characterized pathogenic
hAIF mutants show a substantially decrease in CTC lifetime,
suggesting that its stability is crucial for mitochondrial
homeostasis and human health [18, 45]. Further molecular
and cellular studies will be required to determine the impact
of these pathogenic mutations on the hAIF intracellular pro-
cessing and interaction with its physiological partners, as well
as their link to their multiple clinical neurodegenerative
phenotypes.
4. Conclusions
This report provides insights into the role in hAIF of W196
and β-hairpin motif in the molecular basis of its cellular
activities. Our mutational study shows that, contrary to the
pathogenic ΔR201 mutation—another residue located in
the β-hairpin and involved in the interaction with the regula-
tory C-loop—, changes at W196 residue hardly impact the
overall conformational folding of hAIF in oxidized and
NADH-reduced states. Nonetheless, W196 is key to stabilize
β-hairpin motif conformation by contacts that are substan-
tially diminished and impaired in all characterized W196
variants. Moreover, the W196 and the β-hairpin motif con-
formation strongly modulate the redox-linked monomer-
dimer structural transition in hAIF. The size and aromaticity
of the side chain of W196 is key to (i) maintain the proper β-
hairpin position that stabilizes and retains the regulatory C-
loop in the protein score of oxidized hAIF, favoring protein
compactness and stability; (ii) configure the NADH active
site making hAIF inefficient for NADH oxidation and trigger
the C-loop release to the solvent in the reduced state: critical
factors for CTC stability and mitochondrial homeostasis; and
(iii) define the interaction surfaces with CHCHD4, CypA,
and DNA, by modulating the enthalpic and entropic contri-
butions to the free energy of binding. These features contrib-
ute to modulate hAIF monomer-dimer equilibrium in a
cellular context, which might be relevant for its proper func-
tion as a redox sensor of NAD(H/+) levels and for its interac-
tion network.
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